Distributing since 1889 • Employee Owned for Better Service
Your 1st Choice!
Sign In
Quick Search:

Shopping Cart Cart |  My Account |  View Printable Page Print
Product Detail
ebc item NOTICE: This is the ProQuest Ebook Central� format of this title. What is ProQuest Ebook Central�?
Other formats: Softcover All Formats

Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2017 (Orange Guide)

MHRA
Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2017 (Orange Guide) Cover Image
Pricing & Availability
Available: Yes*
This title does not qualify for any discount.

Email this title to a friend Email this title to a friend
Printer friendly version Printer friendly version

Other formats:
Book Information
Edition: 1st
Publisher: Pharmaceutical Press
ISBN: 0-85711-292-9 (0857112929)
ISBN-13: 978-0-85711-292-7 (9780857112927)
Format: British
Binding: E E Book + ProQuest Ebook Central
Copyright: 2017
Publish Date: 01/17
Volume: 2017
Weight: 0.00 Lbs.
Subject Class: PHM (Pharmacy and Pharmaceutical Industry)
Return Policy: Non-Returnable.
   
ProQuest Ebook Central�: eBook Please sign in to preview this title
 
Class Specifications
Discipline: Pharmacology
Subject Definition: Legislation, Drug-Europe-Great Britain-Guideline
NLM Class: QV 33
LC Class: RS192
Abstract: Familiarly known as the Orange Guide, this title is an essential reference work for all those involved in the manufacture and distribution of medicines in Europe. It is compiled by the UK drug regulatory body, MHRA, and brings together the European and UK guidance documents and information on legislation relating to the manufacture and distribution of medicines for human use. It contains EU guidance on good manufacturing and good distribution practice along with relevant information on EU and UK legislation. ... Revised Annex 16. The GMP Guide Annex 16 has been revised to reflect the globalisation of the pharmaceutical supply chains and the introduction of new quality control strategies. The revision has been carried out in the light of Directive 2011/62/EU amending Directive 2001/83/EC as regards the prevention of the entry into the legal supply chain of falsified medicinal products. This version also implements ICH Q8, Q9 and Q10 documents, and interpretation documents, such as the manufacturing and importation authorisation (MIA) interpretation document, as applicable. Also, some areas, where the interpretation by Member States has not been consistent, have been clarified. This revised Annex came into operation 15 April 2016.
* Subject to ProQuest Ebook Central� availability

Follow Matthews Book Co. on:
Follow Matthews Book Co. on Twitter

Copyright © 2001-2026 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews Privacy Statement